Unitedhealth Group, Inc. hosted its conference call at 8:45 AM ET on July 15, 2022.
Revenues for the UnitedHealth Group increased by $9 billion or 13% to $80.3 billion in the second quarter of 2022, representing double-digit growth at both Optum and UnitedHealthcare.
Operating income for the second quarter of 2022 was $7.1 billion, with contributions from all parts of the company. Adjusted net income of $5.57 per share represented a 19% year-over-year increase.
Due to COVID effects and business mix, the medical care ratio in the second quarter of 2022 was 81.5 percent as opposed to 82.8 percent in the previous quarter. Favorable medical reserve growth of $890 million as opposed to $500 million in the second quarter of the previous year.
Days claims payable were 50.6, up from 49.1 in the first and second quarters of 2022 and 2021, respectively.
The operating cost ratio for the second quarter of 2022 was 14.6 percent as opposed to 14.5 percent in 2021, demonstrating ongoing efficiency increases offset by business mix and the investments the company is still making to support potential future growth.
For the second quarter of 2022, cash flows from operations were $6.9 billion, or 1.3 times net income. In the second quarter, the company returned $4 billion to shareholders through dividends and share repurchases, and the dividend was increased by 14% in June 2022.
The quarter’s return on equity of 27.9 percent reflected the company’s consistent earnings growth profile and efficient capital structure.
UnitedHealthcare is a global health care provider that serves individuals, employers, and Medicare and Medicaid beneficiaries.
UnitedHealthcare is committed to increasing the value customers and consumers receive by improving health and wellness, improving care quality, simplifying the health care experience, and lowering total cost of care.
Disclaimer:
All information has been prepared by TraderFactor or partners. The information does not contain a record of TraderFactor or partner’s prices or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may read it. Past performance is not a reliable indicator of future performance.
